From: In silico assessment of chronic toxicity of a combination drug namely ‘Olmesartan medoxomil and Hydrochlorothiazide’, marketed in Bangladesh
Compound
Volume (cm3)
Mass (amu)
H bond donor
H bond acceptor
Log P
Olmesartan medoxomil
403.5 ± 7.0
558.2
4
7
5.23
Hydrochlorothiazide
175.8 ± 3.0
297.7
2
10
− 0.07